Skip to content
healthcare.dev
Get a free key

EVRYSDI

NDC 50242-202, Risdiplam, tablet, from Genentech, Inc..

Product NDC
50242-202
Status
Listed
Labeler
Genentech, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219285
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-202 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISDIPLAM5 mg/1

Pharmacologic classes

Increased Protein Synthesis [PE]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]; Survival of Motor Neuron 2 Splicing Modifier [EPC]; Survival of Motor Neuron 2 Splicing Modifiers [MoA]

Package NDCNDC-11Package
50242-202-01502420202011 BOTTLE, PLASTIC in 1 CARTON (50242-202-01) / 30 TABLET in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/eceb9a99-7191-4be5-87c3-0102707cf98e

Use it

Look up 50242-202 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-202 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-202. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.